Almac licenses the Rosetta Resolver® system for use in the development of microarray-based approaches for diagnosing cancer. with the Breaking Science News daily newsletter ...
Morning Overview on MSN
Scientists uncover genetic switch that makes pancreatic cancer chemo-proof
Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.
By tagging neurons with molecular "barcodes," researchers have mapped connections among thousands of neurons in the mouse ...
Tina de los Reyes is the strategic biopharma development specialist for the Western US. With over 10 years of commercial experience in NGS and a Masters in Biomedical diagnostics, she specializes in ...
Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...
In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.
This study generated two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules. with the Breaking Science News ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results